BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
Metrics to compare | BP8 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBP8PeersSector | |
---|---|---|---|---|
P/E Ratio | −0.7x | −2.8x | −0.6x | |
PEG Ratio | −0.01 | 0.03 | 0.00 | |
Price/Book | −1.0x | 2.4x | 2.6x | |
Price / LTM Sales | 12.9x | 10.4x | 3.1x | |
Upside (Analyst Target) | - | 289.8% | 51.3% | |
Fair Value Upside | Unlock | −0.7% | 7.3% | Unlock |